Source: Annual Congress 2010 - New insights into reactive oxygen species
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
U. Farkhutdinov, V. Petryakov, S. Farkhutdinov (Ufa, Russian Federation). Antioxidant properties of ambroxol in chronic obstructive pulmonary disease. Eur Respir J 2010; 36: Suppl. 54, 3733

Member's Comments

No comment yet.

Related content which might interest you: Role of inhaled antioxidants in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005 Immunomodulatory efficacy of inferon in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: management Year: 2010 Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease Source: Eur Respir J 2004; 23: 629-636 Year: 2004 Application of erdosteine in the treatment of occupational chronic obstructive pulmonary disease Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2014; 65: 1-17 Year: 2014 Chronic obstructive pulmonary disease Source: Eur Respir Mon; 2009: 45: 25–31 Year: 2009 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2015; 70: 80-98 Year: 2015 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2013; 62: 1-18 Year: 2013 Tiotropium in the management of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 205-206 Year: 2002 Bronchodilators in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=266 Year: 2006 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2014; 44: 475-482 Year: 2014 Minimal bronchiectasis in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 Effects of inhaled Iloprost on hemodynamics in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002 Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Activity limitations in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Physical activity, methodology and impact Year: 2011 The effect of short-acting beta-two-agonist on pulmonary rehabilitation in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease Year: 2009